Oxford pauses AstraZeneca Vaccine

Britain Medicines and Healthcare products Regulatory Agency (MHRA) is one of many bodies across the globe analysing real-world data from the AstraZeneca rollout to see if there is a definitive link between the jab and a rare form of a blood clot after cases were initially reported in Norway and continental Europe.

The WHO and the European Medicines Agency (EMA) will reveal their findings later this week.

University of Oxford on Tuesday announced that it is temporarily pausing the administration of COVID-19 vaccine doses it developed with AstraZeneca PLC in a small UK study to test the shot in children and teenagers.

An Oxford spokesman told the Wall Street Journal that no safety issues have arisen in the trial itself, but broader concerns about rare clotting problems in adults have triggered further regulatory reviews in the U.K. and Europe to investigate any potential link with the vaccine.

“Parents and children should continue to attend all scheduled visits and can contact the trial sites if they have any questions

Published by Naresh Sagar

Mentor MSME, Motivator, Media Event Org, Management fiscal & Water management.Social Media branding,Internet broadcasters,Propunder of Indian Philosophy

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: